Subgroups according to BASDAI/ASDAS category (baseline)
Por um escritor misterioso
Descrição
Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis, Health and Quality of Life Outcomes
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial - The Lancet
Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis
WO2021067465A1 - Treating spondyloarthritic and psoriatic conditions with upadacitinib - Google Patents
Additional Data in Active PsA
Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
Baseline values and 3-month response in subgroups according to CRP
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials
Change from baseline in BASFI, BASDAI, BASMI linear and ASDAS, and
